[go: up one dir, main page]

FI930270L - Cefalosporiner och homologer, framstaellningsfoerfaranden samt farmaceutiska kompositioner - Google Patents

Cefalosporiner och homologer, framstaellningsfoerfaranden samt farmaceutiska kompositioner Download PDF

Info

Publication number
FI930270L
FI930270L FI930270A FI930270A FI930270L FI 930270 L FI930270 L FI 930270L FI 930270 A FI930270 A FI 930270A FI 930270 A FI930270 A FI 930270A FI 930270 L FI930270 L FI 930270L
Authority
FI
Finland
Prior art keywords
framstaellningsfoerfaranden
farmaceutiska
cefalosporiner
homologer
kompositioner
Prior art date
Application number
FI930270A
Other languages
English (en)
Other versions
FI930270A0 (fi
FI930270A7 (fi
Inventor
John Hargreaves Bateson
George Burton
Stephen Christopher Marti Fell
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016189A external-priority patent/GB9016189D0/en
Priority claimed from GB919109540A external-priority patent/GB9109540D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of FI930270A0 publication Critical patent/FI930270A0/fi
Publication of FI930270L publication Critical patent/FI930270L/fi
Publication of FI930270A7 publication Critical patent/FI930270A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI930270A 1990-07-24 1991-07-22 Kefalosporiinit ja homologit, valmistusmenetelmät sekä farmaseuttiset koostumukset FI930270A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909016189A GB9016189D0 (en) 1990-07-24 1990-07-24 Novel compounds
GB919109540A GB9109540D0 (en) 1991-05-02 1991-05-02 Novel compounds
PCT/GB1991/001228 WO1992001696A1 (en) 1990-07-24 1991-07-22 Cephalosporins and homologues, preparations and pharmaceutical compositions

Publications (3)

Publication Number Publication Date
FI930270A0 FI930270A0 (fi) 1993-01-22
FI930270L true FI930270L (fi) 1993-03-22
FI930270A7 FI930270A7 (fi) 1993-03-22

Family

ID=26297372

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930270A FI930270A7 (fi) 1990-07-24 1991-07-22 Kefalosporiinit ja homologit, valmistusmenetelmät sekä farmaseuttiset koostumukset

Country Status (26)

Country Link
EP (2) EP0540606A1 (fi)
JP (2) JP2851428B2 (fi)
KR (1) KR100189075B1 (fi)
CN (2) CN1061046C (fi)
AP (1) AP832A (fi)
AT (1) ATE185567T1 (fi)
AU (1) AU648329B2 (fi)
CA (2) CA2359744C (fi)
CZ (1) CZ6493A3 (fi)
DE (2) DE122006000065I2 (fi)
DK (1) DK0540609T3 (fi)
ES (1) ES2137162T3 (fi)
FI (1) FI930270A7 (fi)
GR (1) GR3031711T3 (fi)
HU (1) HUT63628A (fi)
IE (1) IE912569A1 (fi)
IL (1) IL98909A0 (fi)
LU (1) LU91290I2 (fi)
MX (1) MX9100317A (fi)
MY (1) MY106399A (fi)
NL (1) NL300249I2 (fi)
NO (1) NO930226L (fi)
NZ (1) NZ239061A (fi)
PT (1) PT98426A (fi)
WO (2) WO1992001696A1 (fi)
YU (1) YU129691A (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125645D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compounds
JPH07503460A (ja) * 1992-01-22 1995-04-13 ファイザー・インコーポレイテッド ２−イソセフェムおよびオキサセファム誘導体，それらの製法，その中間体および抗菌剤としての使用
GB9212609D0 (en) * 1992-06-13 1992-07-29 Smithkline Beecham Plc Novel compounds
GB9213567D0 (en) * 1992-06-26 1992-08-12 Smithkline Beecham Plc Novel compounds
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation
AU4398297A (en) * 1996-10-02 1998-04-24 Daiichi Pharmaceutical Co., Ltd. Method for esterifying carboxylic compounds
FR2776292B1 (fr) 1998-03-20 2004-09-10 Oncopharm Cephalotaxanes porteurs de chaine laterale et leur procede de synthese
GB0019124D0 (en) 2000-08-03 2000-09-27 Pfizer Novel process
ES2257471T3 (es) * 2000-12-04 2006-08-01 Pfizer Products Inc. Procedimiento y derivados esteres utiles para la preparacion de cefalosporinas.
KR100526379B1 (ko) * 2000-12-04 2005-11-08 화이자 프로덕츠 인크. 세팔로스포린 제조에 유용한 커플링법 및 중간체
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
KR100710555B1 (ko) 2001-12-04 2007-04-24 에스케이 주식회사 광학적으로 순수한 (ｒ)-폼 또는 (ｓ)-폼의테트라히드로퓨라닐 케톤의 제조방법
UA117095C2 (uk) 2011-12-22 2018-06-25 Аліос Біофарма, Інк. Нуклеозидна сполука або її фармацевтично прийнятна сіль
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
SG11201407336PA (en) 2012-05-25 2015-03-30 Janssen Sciences Ireland Uc Uracyl spirooxetane nucleosides
KR102788773B1 (ko) 2012-12-21 2025-03-28 얀센 바이오파마, 인코퍼레이트. 치환된 뉴클레오사이드, 뉴클레오타이드 및 그것의 유사체
CN105254648B (zh) * 2015-11-13 2018-04-03 广东温氏大华农生物科技有限公司 一种头孢维星及其钠盐的合成方法
GB2575261B (en) 2018-07-02 2022-03-09 Norbrook Lab Ltd Intermediates in the synthesis of C3-substituted cephalosporins
SG11202101429YA (en) 2018-08-23 2021-03-30 Seagen Inc Anti-tigit antibodies
BR112022010924A2 (pt) 2019-12-06 2022-09-06 Vertex Pharma Tetra-hidrofuranos substituídos como moduladores de canais de sódio
CN115135383B (zh) 2020-02-18 2024-06-11 吉利德科学公司 抗病毒化合物
TWI874791B (zh) 2020-02-18 2025-03-01 美商基利科學股份有限公司 抗病毒化合物
TWI883391B (zh) 2020-02-18 2025-05-11 美商基利科學股份有限公司 抗病毒化合物
CN111620893B (zh) * 2020-06-08 2021-12-14 重庆医药高等专科学校 C-3位四氢呋喃取代的头孢菌素-铁载体耦合物及其制备方法和应用
CA3216162A1 (en) 2021-04-16 2022-10-20 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
KR20240031300A (ko) 2021-06-04 2024-03-07 버텍스 파마슈티칼스 인코포레이티드 나트륨 채널 조절제로서의 n-(하이드록시알킬 (헤테로)아릴) 테트라하이드로푸란 카르복스아미드
CA3228162A1 (en) 2021-08-18 2023-02-23 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same
CN121181574A (zh) * 2025-11-24 2025-12-23 重庆汉佩生物科技有限公司 一种头孢维星衍生物和应用以及制备方法
CN121181573A (zh) * 2025-11-24 2025-12-23 重庆汉佩生物科技有限公司 一种含c-3位四氢呋喃头孢菌素衍生物和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793448A (fr) * 1971-12-31 1973-06-28 Roussel Uclaf Procede de preparation de nouveaux derives des cephalosporines et produits obtenus
FR2197573A1 (en) * 1972-09-07 1974-03-29 Roussel Uclaf 7-substd-phenylacetamido-cephalosporin derivs - - antibiotics active against streptococci and staphylococci
BE791161A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Procede pour la preparation d'analogues des cephalosporines
BE791160A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Nouveaux cephemes substitues
NL7305936A (fi) * 1972-05-05 1973-11-07
JPS5849382A (ja) * 1981-09-18 1983-03-23 Kyowa Hakko Kogyo Co Ltd β−ラクタム化合物
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
ATE171705T1 (de) * 1989-03-30 1998-10-15 Pfizer Cephalosporine und ihre homologen, verfahren zu ihrer herstellung und pharmazeutische präparate

Also Published As

Publication number Publication date
LU91290I2 (fr) 2007-01-22
IL98909A0 (en) 1992-07-15
IE912569A1 (en) 1992-01-29
CA2359744C (en) 2007-02-13
CN1223859A (zh) 1999-07-28
MY106399A (en) 1995-05-30
CA2087967A1 (en) 1992-01-25
PT98426A (pt) 1992-05-29
ATE185567T1 (de) 1999-10-15
FI930270A0 (fi) 1993-01-22
JP2851428B2 (ja) 1999-01-27
DE69131714D1 (de) 1999-11-18
WO1992001695A1 (en) 1992-02-06
AP9100305A0 (en) 1991-07-31
DE122006000065I2 (de) 2007-09-13
NO930226D0 (no) 1993-01-22
CN1111410C (zh) 2003-06-18
YU129691A (sh) 1994-01-20
CA2359744A1 (en) 1992-02-06
EP0540609A1 (en) 1993-05-12
DE69131714T2 (de) 2000-02-24
NL300249I1 (nl) 2007-02-01
DE122006000065I1 (de) 2007-03-01
GR3031711T3 (en) 2000-02-29
NO930226L (no) 1993-03-23
NL300249I2 (en) 2007-02-01
DK0540609T3 (da) 1999-12-27
CZ6493A3 (en) 1994-04-13
HU9300177D0 (en) 1993-04-28
EP0540606A1 (en) 1993-05-12
JPH05509089A (ja) 1993-12-16
CN1061046C (zh) 2001-01-24
EP0540609B1 (en) 1999-10-13
CN1060469A (zh) 1992-04-22
JPH05509305A (ja) 1993-12-22
NZ239061A (en) 1993-11-25
AU8222491A (en) 1992-02-18
CA2087967C (en) 2002-09-10
MX9100317A (es) 1992-02-28
AP832A (en) 2000-05-03
KR100189075B1 (ko) 1999-06-01
KR930701456A (ko) 1993-06-11
HUT63628A (en) 1993-09-28
ES2137162T3 (es) 1999-12-16
FI930270A7 (fi) 1993-03-22
WO1992001696A1 (en) 1992-02-06
AU648329B2 (en) 1994-04-21

Similar Documents

Publication Publication Date Title
FI906105A0 (fi) Laett oeppningsbar foerpackningspaose och stoedstaellning samt framstaellningsfoerfarande.
FI930270L (fi) Cefalosporiner och homologer, framstaellningsfoerfaranden samt farmaceutiska kompositioner
FI905843A7 (fi) Foerfarande och anordning foer granskning av rakheten av hissgejder och foer raettande av avrikelser samt maetanordning.
FI920522A0 (fi) Ytaktiva cykliska amidokarboxi- foereningar samt deras syntes och anvaendning.
FI911921A7 (fi) Synkronisationsfoerfarande foer sdh -system samt foerfarande och kopplingsanordning foer igenkaenning av olika datastrukturer.
FI905492A0 (fi) Mejeriprodukt samt foerfarande och anlaeggning foer framstaellning av denna.
FI904370A0 (fi) Foerfarande foer tillverkning av sandwichelement bestaoende av en kaerna av mineralullslameller och ytskikt exempelvis av plaot samt en anordning foer utfoerande av foerfarandet.
FI900494L (fi) Anordning foer ingaongs- och utgaongsluft och luftkonditioneringsfoerfarande.
FI904421A0 (fi) Pyridinylkinolonfoereningar samt deras framstaellning och anvaendning.
FI904281L (fi) Dynamiskt spaenningsintegreringsfoerfarande samt kopplingar foer utfoerande och tillaempande av foerfarandet.
FI911460L (fi) Tillsatsaemnen foer smoerjolja samt deras framstaellning och anvaendning.
FI905920A7 (fi) Foerfarande foer riktande av bergborranordningensmatarbalk samt bergborranordning och maetningsanordning.
FI911462L (fi) Tillsatsaemnen foer smoerjolja samt deras framstaellning och anvaendning.
FI903310A7 (fi) Ledningskanal foer kablar och ledningar samt daertill anslutbara apparatdosor.
FI923763L (fi) Inklaednad av bergvaeggar saosoem tunnlar och dylikt, samt saett foer att aostadkomma inklaednaden
FI911461L (fi) Tillsatsaemnen foer smoerjolja samt deras framstaellning och anvaendning.
FI913563A0 (fi) Foerfarande foer flamraffinering av tenn - och blyhaltigt primaerkoppar och kopparavfall i invaendigt basiskt beklaedda ungnar samt en slaggbildningsblandning foer utfoerande av dylik raffinering.
FI921551A0 (fi) Indolderivat samt deras fram- staellning och anvaendning.
FI902014A0 (fi) Foerfarande och anordning foer skjutoevning.
FI900479A0 (fi) Foerfarande och anordning foer predikterande kodning.
FI900276A7 (fi) Stenelement samt foerfarande och anordning foer bearbetning av detsamma.
FI910643A7 (fi) Inspelning samt foerfarande och anordning foer inspelnings- och ljudalstring.
FI900132A0 (fi) Tryckreglering i oljeeldstad och styrning v vaermevaexling.
FI924818A0 (fi) Cdr-ympade anti-icam-1-antikroppar foer maenniskobruk, foerfaranden foer deras framstaellning samt deras anvaendning
FI83361B (fi) Fogkonstruktion och foerstycke.